Suchergebnisse - C Scheid

Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency von F. Jakobs, P. Ahmadi, V. Osterkamp, J. Jeck, U. Holtick, C. Scheid, Florian Kron

Volltext

A Worksite Nutrition Intervention is Effective at Improving Employee Well-Being: A Pilot Study von Jay T. Sutliffe, Mary Jo Carnot, Joel H. Fuhrman, Chloe A. Sutliffe, Julia C. Scheid

Volltext

Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation von T. Richardson, D. Schütte, K. Feyer, L. Grass, M. Hallek, C. Scheid, F. Simon, T. Braun, M. Fürstenau, P. Gödel, U. Holtick

Volltext

Author Correction: Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation von T. Richardson, D. Schütte, K. Feyer, L. Grass, M. Hallek, C. Scheid, F. Simon, T. Braun, M. Fürstenau, P. Gödel, U. Holtick

Volltext

P10.01 Nutritional and immunometabolic measures for risk assessment in allogeneic hematopoietic stem cell transplantation von S Theurich, M von Bergwelt-Baildon, M Funk, K Althoff, S Leitzke, U Holtick, C Scheid, D Cordas dos Santos, S Oganesian, H Thurisch

P1069: RETROSPECTIVE COMPARISON OF PATIENT OUTCOMES ON PACRITINIB VERSUS RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS AND THROMBOCYTOPENIA von C. Harrison, P. Bose, R. Mesa, A. Gerds, S. Oh, J.-J. Kiladjian, V. García-Gutierrez, A. Vannucchi, C. Scheid, M. Sobas, S. Verstovsek, S. Buckley, K. Roman-Torres, J. Mascarenhas

Volltext

P879: EXENT AND FLC MASS SPECTROMETRY FOR SEROLOGICAL IDENTIFICATION AND QUANTIFICATION OF MONOCLONAL IMMUNOGLOBULINS IN MULTIPLE MYELOMA von S. Huhn, A. M. Poos, E. K. Mai, M. Hänel, H. J. Salwender, J. Dürig, I. W. Blau, C. Scheid, K. C. Weisel, M. Munder, O. Berlanga, U. Bertsch, H. Goldschmidt, N. Weinhold

Volltext

P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT von P. Borchmann, A. Lohneis, P. Gödel, H. Balke-Want, C. Schmid, F. Ayuk, S. Holtkamp, L. Hanssens, G. Zadoyan, B. Friedrichs, M. Assenmacher, I. Bürger, D. Schneider, T. Overstijns, C. Scheid, U. Holtick, S. Miltenyi, M. Hallek

Volltext

P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESS... von H Einsele, AD Cohen, M Delforge, J Hillengass, H Goldschmidt, K Weisel, M-S Raab, C Scheid, JM Schecter, KC De Braganca, H Varsos, T-M Yeh, L Wang, M Vogel, C Corsale, M Akram, L Pacaud, T Nesheiwat, M Agha, YC Cohen

Volltext

P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES... von J. Hillengass, A. D. Cohen, M. Delforge, H. Einsele, H. Goldschmidt, K. Weisel, M.-S. Raab, C. Scheid, J. M. Schecter, K. C. De Braganca, H. Varsos, T.-M. Yeh, P. Mistry, T. Roccia, C. Corsale, M. Akram, L. Pacaud, T. Nesheiwat, M. Agha, Y. C. Cohen

Volltext

P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA von F. Stegelmann, E. Jahn, S. Koschmieder, F. Heidel, A. Hochhaus, H. Hebart, S. Isfort, A. Reiter, M. Bangerter, C. F. Waller, D. Wolleschak, C. Scheid, J. Göthert, P. Schafhausen, T. Kindler, M. P. Radsak, N. Gattermann, R. Möhle, N. von Bubnoff, A. Schrade, T. Brümmendorf, H. Döhner, M. Griesshammer, K. Döhner

Volltext

C021 | IMPACT ON OUTCOMES OF RESPONSE TO HIGH-DOSE METHOTREXAT-BASED INDUCTION AND CONSOLIDATION REGIMEN IN 1,545 PATIENTS WITH PRIMARY CNS LYMPHOMA TREATED WITH AUTOLOGOUS STEM-CE... von T. Calimeri, M. Fekom, P. Fiore, P. Lopez Pereira, C. Fox, G. Illerhaus, R. Zeiser, K. Cywnarski, H. Ghesquieres, W. Bethge, C. Scheid, D. Richardson, U. Novak, F. Stölzel, M. Trneny, G. Cassanello, A. Mussetti, B. Glass, C. Thieblemont, A. Sureda, A. Bazarbachi, A. J. M. Ferreri

Volltext

P958: REAL-LIFE CURRENT STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSES FROM THE LOCOMMOTION STUDY von H. Einsele, P. Moreau, V. De Stefano, D. Dytfeld, E. Angelucci, R. Benjamin, H. Goldschmidt, N. W. van de Donk, B. Besemer, C. Scheid, R. Vij, E. I. ’. Groen-Damen, M. Semerjian, V. Strulev, J. M. Schecter, T. Roccia, T. Nesheiwat, R. Wapenaar, K. Weisel, M.-V. Mateos

Volltext

P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FRO... von E. K. Mai, U. Bertsch, R. Fenk, D. Tichy, B. Besemer, J. Dürig, R. Schroers, I. von Metzler, M. Hänel, C. Mann, A. M. Asemissen, B. Heilmeier, E. Nievergall, S. Huhn, K. Kriegsmann, N. Weinhold, S. Luntz, T. A. W. Holderrried, K. Trautmann-Grill, D. Gezer, M. Klaiber-Hakimi, M. Müller, C. Khandanpour, W. Knauf, C. Scheid, M. Munder, T. Geer, H. Riesenberg, J. Thomalla, M. Hoffmann, M. S. Raab, H. J. Salwender, K. C. Weisel, H. Goldschmidt

Volltext

P11 | PERIPHERAL MEASURABLE RESIDUAL DISEASE ACTIVITY ASSESSMENT BY MALDI-TOF MASS SPECTROMETRY IN PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA IN THE PHASE 3 GMMG-HD7 TRIAL von J.X. Jin, V.R. Ginde, S. Huhn, Ph. Reichert, U. Bertsch, R. Fenk, B. Besemer, A. Boquoi, R. Schroers, I. Von Metzler, M. Hänel, Ch. Mann, L.B. Leypoldt, B. Heilmeier, C. Scheid, T. Peters-Regehr, I.W. Blau, C. Müller-Tidow, S. Luntz, T.A.W. Holderried, K. Trautmann-Grill, D. Gezer, M. Klaiber-Hakimi, M. Müller, E. Shumilov, W. Knauf, C.S. Michel, T. Geer, H. Riesenberg, Ch. Lutz, M.S. Raab, N. Weinhold, M. Hoffmann, A. Benner, P. Findeisen, K.C. Weisel, H.J. Salwender, H. Goldschmidt, E.K. Mai

Volltext